SavedAdd your journal

Journals / Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2021 / Cilt: 11 - Sayı: 1

Comparison of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seropositivity of Turkish and Refugee Pregnant Women

Türk ve Mülteci Gebelerde HBsAg, Anti-HBs, Anti-HCV ve Anti-HIV Seropozitifliklerinin Karşılaştırılması

Şerife YILMAZ
Sibel Mutlu
Pages
21–24
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rates of anti-HBs seropositivity between Turkish and refugee pregnant women were 38.4% and 22.2%, respectively, and the difference was significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Our aim is to investigate the seropositivity of HBsAg, anti-HBs, anti-HCV and anti-HIV in pregnant women and compare the seropositivity of these parameters of refugee and Turkish pregnant women in our region.
📊
Key Findings & Data:Material and Methods: In our study, HBsAg, anti-HBs, anti-HCV and anti-HIV results of Turkish and refugee pregnant women who presented at Karabuk University Training and Research Hospital between 2017-2019 were analyzed and compared retrospectively.
💡
Conclusion & Impact:The rates of anti-HBs seropositivity between Turkish and refugee pregnant women were 38.4% and 22.2%, respectively, and the difference was significant (p
🔬Design:Research Article
📍Scope:2017-2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Our aim is to investigate the seropositivity of HBsAg, anti-HBs, anti-HCV and anti-HIV in pregnant women and compare the seropositivity of these parameters of refugee and Turkish pregnant women in our region. Material and Methods: In our study, HBsAg, anti-HBs, anti-HCV and anti-HIV results of Turkish and refugee pregnant women who presented at Karabuk University Training and Research Hospital between 2017-2019 were analyzed and compared retrospectively. Results: The 3382 pregnant women were comprised of 3152 (93.2%) Turkish and 230 (6.8%) refugee pregnant women. In all pregnant women, the rates of HBsAg, anti-HBs, anti-HCV and anti-HIV seropositivity were 0.68%, 37.2%, 0.08% and 0%, respectively. The rates of anti-HBs seropositivity between Turkish and refugee pregnant women were 38.4% and 22.2%, respectively, and the difference was significant (p

Özet

Amaç: Bu çalışmada amacımız bölgemizdeki gebelerde HBsAg, anti-HBs, anti-HCV ve anti-HIV seropozitifliğinibelirlemek ve mülteci gebeler ile Türk gebelerin sonuçlarını karşılaştırmaktır.Gereç ve Yöntemler: Çalışmamızda 2017-2019 tarihleri arasında Karabük Üniversitesi Eğitim Araştırma Hastanesi’nebaşvuran Türk ve mülteci gebelerin HBsAg, anti-HBs, anti-HCV ve anti-HIV sonuçları retrospektif olarak irdelenmişve iki grup arasında karşılaştırma yapılmıştır.Bulgular: Çalışmamıza 3382 gebe dahil edilmiş olup 3152 (%93,2) si Türk, 230 (%6,8) u mülteci gebelerdenoluşmaktadır. Tüm gebelerde HBsAg, anti-HBs, anti-HCV ve anti-HIV seropozitifliği sırasıyla %0,68; %37,2; %0,08ve %0 dır. Türk gebeler ile mülteci gebeler arasında anti-HBs seropozitiflik oranı sırasıyla %38,4 ve %22,2 oluparadaki fark anlamlı bulunmuştur (p

🔖

Cite This Article

YILMAZ, Ş., Mutlu, S. (2022). Comparison of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seropositivity of Turkish and Refugee Pregnant Women. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 11 - Sayı: 1, 21–24. https://ajindex.com/articles/494667

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yalçın Bahat P, Turan G, Yüksel Özgör B, Bağcı Çakmak K. Comparison of hepatitis B, hepatitis C, and HIV seropositivity of Syrian and Turkish pregnant women. Turk J Obstet Gynecol. 2019; 16 (2): 95-9
  2. Tosun S. Pregnancy and hepatitis B virus infection. Mediterr J Infect Microb Antimicrob. 2016; 5: 4 3. Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal hepatitis B virus transmission. J Pediatric Infect Dis Soc. 2014; 3(1): 7-12
  3. Centers for Disease Control (CDC). Postexposure prophylaxis of hepatitis B. MMWR Morb Mortal Wkly Rep. 1984; 33(21): 285-90
  4. Gülcü S, Arslan S. Çocuklarda aşı uygulamaları: güncel bir gözden geçirme. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2018; 8(1): 34-43
  5. Jhaveri R, Swamy GK. Hepatitis C virus in pregnancy and early childhood: current understanding and knowledge deficits. J Pediatric Infect Dis Soc. 2014; 3(1): 13-8
  6. Hughes BL, Page CM, Kuller JA. Hepatitis C in pregnancy: screening, treatment, and management. American Journal of Obstetrics and Gynecology. 2017; 217(5): 2-12
  7. Kölgelier S, Demir LS, Demir NA, Özçimen S, Tabak S. Seropositivity of HBsAg and anti-HCV in pregnant women in Adıyaman. Viral Hepatit Dergisi. 2012; 18(3): 98-101
  8. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006; 55(14): 1-17
  9. Sanhal C, Ataman Ç, Özel Ş, Üstün Y. Gebelikte HIV enfeksiyonu. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. 2018; 15(2): 87-9
  10. Uzun B, Gungor S, Er H, Pektas B, Demirci M. İzmir Atatürk Eğitim Araştırma Hastanesine başvuran poliklinik hastalarında HBsAg, Anti-HCV, Anti-HIV seroprevalansı. Viral Hepatit Dergisi. 2013; 19(3): 123-5
  11. Madendağ Y, Madendağ İ, Çelen Ş, Ünlü S, Danışman N. Seroprevalence of hepatitis B, hepatitis C and HIV at whole obstetric and gynecologic patients who applied our hospital. Journal of Clinical Obstetrics & Gynecology. 2007; 17(6): 442-6
  12. Aynioğlu A, Aynioglu O, Akar T, Aydın M, Altunok E. HBsAg, Anti-HBs and anti-HCV seropositivity rates among pregnant women attending a university hospital in Zonguldak. Viral Hepatitis Journal. 2015; 21(1): 31-4
  13. İnci A, Yıldırım D, Seçkin K, Gedikbasi A. Analysis of HbsAg positivity rate before and after vaccination in Turkish and Syrian refugee pregnant women. J Infect Dev Ctries. 2017; 11(10): 8